Polymorphisms in genes involved in other autoimmune disorders, including cytotoxic T-lymphocyte associated protein 4 (CTLA-4) and protein tyrosine phosphatase non-receptor type 22 (PTPN22) among others, have been identified as additional risk factors for APS-2 [44,45]. This evidence concerns the gene PTPN22 and autoimmune disease.